skip to Main Content

Maximize your investment and minimize risk

with Canada’s go-to-market experts.

Unlock the value of Canada’s public and private markets with:

On-the-ground senior strategists

Experienced CEOs and functional experts in every essential area

Strategic counsel on key business options

  • Out-licensing
  • Strategic alliance / partnership
  • Stand-alone affiliate

Tactical planning and customized support for strategy implementation

Smart, eh?


Whatever your needs—end-to-end commercialization or customized services—Accelera Canada provides the same rigor you use in your R&D clinical development efforts applied to your commercialization process.

arrow capability




Michael Cloutier, Founding Partner

  • CEO/President/GM of seven Canadian companies and affiliates including: Searle, Pharmacia, AstraZeneca, COTI, InterMune, PTC Therapeutics, Canadian Diabetes Association
  • International Experience (US, Europe, Latin America) in global marketing, operations and human resources
  • Network of over 3000 individuals in Canada/US/EU
  • Advanced Insight and Market Relationships: Board Chair OBIO (Ontario Bioscience Innovation Organization); Board Member Joule (Canadian Medical Association Affiliate); Board Member Cameron Institute



Deborah Brown, Managing Partner

  • Extensive North American leadership experience including:
    • President, EMD Serono Canada (division of Merck KGaA, Merck Serono)
    • Executive VP, Neuroimmunology, North America, Serono
    • Deep Bench Strength in both commercial and technical functions:
    • BU Director, Marketing, Regulatory, Quality Affairs & Medical Research, Clinical Data Analyses
  • Long term advocate for thriving Canadian health sciences ecosystem:
    • Board Member of Life Sciences Ontario (LSO)
    • Former Board Chair & Exec Committee Member of Rx&D
    • Former Board Member & Exec Committee of BIOTECanada



Robert Kulik, Senior Partner, Market Access Strategy & Pricing

  • Co-Founder Patient Access Solutions Inc.
  • 20 years of pharmaceutical and biotech experience
  • Proven success in:
    • Market access strategy
    • Provincial and pan-Canadian negotiation strategy
    • Public affairs and stakeholder relations
    • Pricing
    • Patient access programs and strategies
    • Health policy and drugs for rare diseases and targeted populations
    • Canadian commercialization



Lindy Forte, Senior Partner, Market Access & Scientific Affairs

  • Co-Founder Patient Access Solutions Inc.
  • 20 years of pharmaceutical and biotech experience
  • Proven success in:
    • Market access strategy
    • Development of formulary submissions (CDR, pCODR, provincial, private, and hospital)
    • Outcomes research
    • Health economics
    • Budget impact analysis/market forecasting
    • Medical marketing and medical writing
    • Drugs for rare diseases and targeted populations



Ryan Clarke, Senior Partner, Stakeholder Relations & Advocacy

  • CEO and Founder, Advocacy Solutions
  • Founded in 2003
  • Business committed to providing a voice to organizations and individuals through the development and implementation of impactful advocacy strategies
  • Three core services:
    • Training and development
    • Creation of strategic plans
    • Implementation of strategies


Back To Top